Full Year 2024 Oneview Healthcare PLC Earnings Call Transcript
Key Points
- Revenue for the year increased by 5% to EUR9.9 million, despite delays in customer deployments.
- Recurring revenue grew by 9% to EUR7.2 million, indicating strong ongoing customer engagement.
- Gross margins remained strong at 67%, consistent with the previous year.
- The company added eight major new logos in the United States, a record for any 12-month period.
- The partnership with Baxter was extended for two more years and expanded to include the Canadian market, enhancing market reach.
- Two significant customer deployment projects were postponed, impacting revenue for the year.
- The adjusted EBITDA loss for the year was EUR8.8 million, influenced by delayed projects and increased investment in resources.
- The company faces challenges in the private hospital market in Australia, affecting potential growth in that region.
- Customer churn is primarily due to financially challenged customers unable to refresh hardware, impacting revenue stability.
- Hardware prices, although decreasing, still pose a challenge in terms of affordability for some customers.
Thank you for standing by, and welcome to the Oneview Healthcare plc preliminary FY24 results presentation call. (Operator Instructions)
I would now like to hand the conference over to Mr. James Fitter, CEO. Please go ahead.
Thanks, Darcy. Good morning, everyone. Good afternoon in the United States, and good evening for those joining in Dublin. First of all, just a usual reminder around the legal disclaimer, particularly with respect to forward-looking statements and a reminder that we are a December year-end, and our reporting currency is euros. In certain circumstances, we have provided a dollar conversion, so please be wary of that. And for those of you joining on the phone, I will try and reference page numbers as we work through the presentation.
Just a reminder, Oneview Healthcare's mission is to improve connected care experiences every day, and our vision is redefine of care, accessible, seamless, and reliable for all and never has that been more of a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
